Femasys Inc insider trading
Every open-market purchase and sale by Femasys Inc's officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
Insider purchases, 5 years $134,000 5 trades by 5 insiders Insider sales, 5 years $0 0 trades by 0 insiders
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Femasys Inc’s insiders pay?
From August 11, 2026 to August 11, 2026, 5 insiders reported 5 open-market purchases and 0 sales not made under a pre-set plan in Femasys Inc.
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Canning John Charles | Chief Operating Officer | 1 | — | — | 0 | — | August 11, 2026 |
| Elefant Dov | Chief Financial Officer | 1 | — | — | 0 | — | August 11, 2026 |
| Lee-Sepsick Kathy | Chief Executive Officer | 1 | — | — | 0 | — | August 11, 2026 |
| Mifek Jeffrey Gerald | Chief Clinical-Medical Affairs | 1 | — | — | 0 | — | August 11, 2026 |
| Sipos Jeremy Alexander | Chief Technology Officer | 1 | — | — | 0 | — | August 11, 2026 |